SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-103832
Filing Date
2019-04-11
Accepted
2019-04-11 16:00:57
Documents
11
Period of Report
2019-04-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d733375d8k.htm 8-K 16698
2 EX-10.1 d733375dex101.htm EX-10.1 70428
3 EX-99.1 d733375dex991.htm EX-99.1 216598
4 EX-99.2 d733375dex992.htm EX-99.2 391814
5 GRAPHIC g733375dsp10.jpg GRAPHIC 116062
6 GRAPHIC g733375g0408110449002.jpg GRAPHIC 6316
7 GRAPHIC g733375g0408110449096.jpg GRAPHIC 6329
8 GRAPHIC g733375g0408110449205.jpg GRAPHIC 5842
9 GRAPHIC g733375g0408110449314.jpg GRAPHIC 5000
10 GRAPHIC g733375g20h31.jpg GRAPHIC 131420
11 GRAPHIC g733375g30u90.jpg GRAPHIC 122795
  Complete submission text file 0001193125-19-103832.txt   1240154
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 19743792
SIC: 2836 Biological Products, (No Diagnostic Substances)